DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
43	顕微鏡的多発血管炎	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00104299 (ClinicalTrials.gov)	January 2005	24/2/2005	Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis	Rituximab Therapy for the Induction of Remission and Tolerance in ANCA-Associated Vasculitis (ITN021AI)	Vasculitis;Wegener's Granulomatosis;Microscopic Polyangiitis	Drug: Rituximab plus cyclophosphamide placebo (rituximab group);Drug: Cyclophosphamide plus rituximab placebo (control group);Drug: Azathioprine;Drug: Methylprednisolone (or other glucocorticoid);Drug: Prednisone	National Institute of Allergy and Infectious Diseases (NIAID)	Immune Tolerance Network (ITN);Genentech, Inc.	Completed	15 Years	N/A	All	197	Phase 2;Phase 3	United States;Netherlands

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00104299
(ClinicalTrials.gov)

January 2005

24/2/2005

Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis

Rituximab Therapy for the Induction of Remission and Tolerance in ANCA-Associated Vasculitis (ITN021AI)

Vasculitis;Wegener's Granulomatosis;Microscopic Polyangiitis

Drug: Rituximab plus cyclophosphamide placebo (rituximab group);Drug: Cyclophosphamide plus rituximab placebo (control group);Drug: Azathioprine;Drug: Methylprednisolone (or other glucocorticoid);Drug: Prednisone

National Institute of Allergy and Infectious Diseases (NIAID)

Immune Tolerance Network (ITN);Genentech, Inc.

Completed

15 Years

N/A

All

197

Phase 2;Phase 3

United States;Netherlands